谢颂平,康敢军,江文洋.CXCR4的表达与肺腺癌顺铂耐药的临床研究[J].肿瘤学杂志,2015,21(7):539-541.
CXCR4的表达与肺腺癌顺铂耐药的临床研究
Expression of CXCR4 and Cisplatin-resistance in Lung Adenocarcinoma
投稿时间:2014-11-03  
DOI:10.11735/j.issn.1671-170X.2015.07.B001
中文关键词:  肺肿瘤  腺癌  CXCR4  顺铂  耐药
英文关键词:lung neoplasms  adenocarcinoma  CXCR4  cisplatin  drug resistance
基金项目:湖北省自然科学基金资助项目(2014CFA070)
作者单位
谢颂平 武汉大学人民医院 
康敢军 武汉大学人民医院 
江文洋 武汉大学人民医院 
摘要点击次数: 1769
全文下载次数: 881
中文摘要:
      摘 要:[目的] 分析CXCR4在肺腺癌中的表达及其与铂类耐药的关系。[方法] 采用免疫组化SP法检测CXCR4在71例ⅢA期肺腺癌中的表达,分析其表达与肺腺癌顺铂耐药及预后的关系。[结果] CXCR4在71例ⅢA期肺腺癌中的阳性表达率为85.9%。耐药组肺癌患者与敏感组相比,CXCR4表达升高,且预后差,两组比较差异有统计学意义(P<0.05)。[结论]CXCR4蛋白阳性表达与ⅢA期肺腺癌顺铂耐药有关。
英文摘要:
      Abstract:[Purpose] To investigate the relationship of CXCR4 expression with cisplatin resistance in lung adenocarcinoma.[Methods] Expression of CXCR4 in 71 specimens of lung adenocarcinoma stage ⅢA was detected immunohistochemically. The relationship of CXCR4 expression with cisplatin resistance and prognosis were analyzed.[Results] The positive rate of CXCR4 in lung adenocarcinoma was 85.9%(61/71).Patients in cisplatin-resistant group had higher expression rate of CXCR4 and worse prognosis compared with patients in cisplatin-sensitive group (P<0.05).[Conclusion] An elevated expression of CXCR4 is correlated with cisplatin resistance in lung adenocarcinoma patients.
在线阅读   查看全文  查看/发表评论  下载PDF阅读器